Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
Dupixent peak sales ambition raised to more than €13 billion
Viralex is an immunomodulatory agent with broad-spectrum antiviral properties. It enhances both innate & adaptive immunity and strengthens the body's defence response to viral infections
These results are being presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
New inhalers would have near-zero Global Warming Potential propellant
The entire integration and transition of the brands is expected to be completed by March 2022
The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation
Subscribe To Our Newsletter & Stay Updated
